CClinicalTrials.gg
RecruitingNCT05681767DEPKuopioUpdated Sep 19, 2025

Motivational Multicomponent Lifestyle Interventions as a Supportive Treatment for Depression in Primary Health Care

An interventional study of Motivational multicomponent lifestyle intervention + Treatment as usual and Treatment as usual in Depression, sponsored by Kuopio University Hospital. Recruiting at 1 site in Finland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-19.

Sponsored by Kuopio University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
210
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The investigators aim to examine whether a motivational multicomponent lifestyle intervention as a supportive treatment for depression has a beneficial effect on recovery from depression in a primary health care setting.

Read the detailed description

Depression causes a significant global burden of disease. Among depressed individuals, poor lifestyles, such as physical inactivity, unhealthy diet, and smoking, are common and play a role in the development and maintenance of depression. Robust research evidence recommends applying one-component lifestyle interventions that focus on factors such as a healthy diet or exercise, as a supportive treatment for depression. Currently, however, there is increasing interest in identifying the most effective multicomponent lifestyle intervention that targets more than one unhealthy lifestyle simultaneously in order to reduce depressive symptoms.

The study aims to examine whether a motivational multicomponent lifestyle intervention as a supportive treatment for depression has a beneficial effect on recovery from depression in a primary health care setting. The specific study questions are as follows:

  1. What is the effect of the intervention on depressive symptoms at 3- and 12-month follow-ups?
  2. What is the effect of the intervention on mental well-being at 3- and 12-month follow-ups?
  3. What kind of physical health do depressed patients in primary health care have? What kinds of effects does the intervention have on common physical health risk factors at 12- and 24- month follow-ups?
  4. What is the effect of the intervention on health-related quality of life?
  5. What is the cost-effectiveness of the intervention?
02

Conditions studied

  • Depression

Browse trials for

03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • adults ≥ 18 years
  • depression (ICD-10, F32-F33)
  • Beck Depression Inventory (BDI-1A) ≥ 10 points
  • the initiation of treatment in a primary health care center

Exclusion criteria

Exclusion Criteria:

  • bipolar disorder
  • psychosis
  • substance abuse
  • pregnancy or lactation
  • a long-term rehabilitative psychotherapy.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
210 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Motivational multicomponent lifestyle intervention + treatment as usual

    Behavioral: Motivational multicomponent lifestyle intervention + Treatment as usual

  • Other
    Control group

    Treatment as usual

    Other: Treatment as usual

Interventions

  • BehavioralMotivational multicomponent lifestyle intervention + Treatment as usual

    Study intervention and treatment as usual The study intervention is a multicomponent lifestyle intervention that targets exercise, diet, and stress management, and is conducted by motivational interviewing. The study nurse provides the study intervention. The intervention is conducted by motivational interviewing and includes the key elements of lifestyle interventions identified as effective (assessment of behavior at the baseline, giving information and advising, individualized goal setting, setting an action plan, monitoring a behavioral change, and giving feedback). The intervention consists of individual appointments (2 x 45-60 min) and a telephone session ( 2 x 15 min) for three months. The participants receive a short educational guide (A4) on the lifestyle behavior recommendations.

  • OtherTreatment as usual

    Treatment as usual

05

What researchers measure

Primary outcomes

  1. Change in Beck Depression Inventory (BDI) scores

    Depressive symptoms

    Time frame: Change from baseline at 3, 12 and 24 months

  2. Change in the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) scores

    Mental Wellbeing

    Time frame: Change from baseline at 3, 12 and 24 months

  3. Change in 15D scores

    Health-Related Quality of Life

    Time frame: Change from baseline at 3, 12 and 24 months

Secondary outcomes

  1. Change in Perceived Stress Scale (PSS-10) scores

    Stress

    Time frame: Change from baseline at 3, 12 and 24 months

  2. Change in Insomnia Severity Index (ISI) scores

    Insomnia

    Time frame: Change from baseline at 3, 12 and 24 months

  3. Change in Numeric Rating Scale for pain

    Pain

    Time frame: Change from baseline at 3, 12 and 24 months

  4. Change in Overall Anxiety Severity and Impairment Scale (OASIS) scores

    Anxiety

    Time frame: Change from baseline at 3, 12 and 24 months

  5. Change in Blood lipid levels

    P-Kol, P-KOL-LDL, P-KOL-HDL, P-Trigly

    Time frame: Change from baseline at 12 and 24 months

  6. Change in weight/body mass index (BMI)

    Change in measured weight/BMI

    Time frame: Change from baseline at 3, 12 and 24 months

  7. Change in waist circumference

    Waist (centimeters)

    Time frame: Change from baseline at 3, 12 and 24 months

  8. Change in Blood pressure (diastolic and systolic)

    Blood pressure (diastolic and systolic)

    Time frame: Change from baseline at 3, 12, and 24 months

  9. Change in Blood glucose levels

    P-Glucose and glycated haemoglobin

    Time frame: Change from baseline at 12 and 24 months

06

Study locations

1 of 1 sites recruiting
  • Kuopio Health Center
    Kuopio, Finland
    • Ulla Mikkonen, MD · Contact
    • Pekka Mäntyselkä, Professor · Contact
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT05681767
Lead sponsor
Kuopio University Hospital
Collaborators
University of Eastern Finland, City of Kuopio, University of Oslo
Responsible party
Sponsor
First posted
Jan 12, 2023
Start date
Nov 21, 2022
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Sep 19, 2025

Study contacts

Pekka Mäntyselkä
Contact
pekka.mantyselka@uef.fi
+35850449436
Ulla Mikkonen
Contact
ulla.mikkonen@uef.fi
Pekka Mäntyselkä
principal investigator · University of Eastern Finland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion